1 in 10 overseas direct-buy food products test positive for hazardous substances Korean inspections found undeclared drug ingredients, banned materials and narcotics in overseas direct-purchase food products. 2026.9.10
Justice minister nominee mirrors president's legal risks (KOR) Kim Seung-won's suspended indictment over alleged clinical trial lobbying intensifies scrutiny of President Lee Jae Myung's Cabinet choice. 2026.9.8
Justice minister nominee mirrors president's legal risks Kim Seung-won's suspended indictment over alleged clinical trial lobbying intensifies scrutiny of President Lee Jae Myung's Cabinet choice. 2026.9.7
Drug Safety Ministry hosts 1st meeting of newly created regulatory agency summit on cosmetics A total of 15 regulatory agencies from 12 countries attended the Global Cosmetic Regulatory Authority Summit in central Seoul on Monday for a three-day run. 2026.9.7
Justice minister nominee faces clinical trial lobbying questions (KOR) Kim Seung-won’s confirmation hearing must examine his role in an expedited biotech trial review and prosecutors’ suspended indictment. 2026.9.3
Justice minister nominee faces clinical trial lobbying questions Kim Seung-won’s confirmation hearing must examine his role in an expedited biotech trial review and prosecutors’ suspended indictment. 2026.9.2
Too good to be true: The challenges of tackling deceptive wellness ads in Korea Regulators recently flagged 26 companies for misleading consumers, but they are still struggling to combat a wave of product scams that use celebrities, AI-generated "experts" and false claims to drive sales. 2026.8.6
Kanpai! Japan's beer exports to Korea topped 100,000 tons for the first time in 2025, rising 22 percent from a year earlier, according to the annual imported food report. 2026.7.5
Japanese beer imports top 100,000 tons for 1st time in 2025 on rising demand Rising demand at convenience stores and supermarkets pushed Japanese beer imports to a record high, making Japan Korea’s top beer supplier by region. 2026.7.5
Eli Lilly Korea to roll out high-dose Mounjaro, sharpening obesity-drug rivalry with Novo Nordisk Eli Lilly Korea is launching higher-dose Mounjaro as competition with Novo Nordisk’s Wegovy intensifies in the country’s booming obesity drug market. 2026.6.9
